395 related articles for article (PubMed ID: 38175479)
1. Clostridioides difficile Biofilm.
Vuotto C; Donelli G; Buckley A; Chilton C
Adv Exp Med Biol; 2024; 1435():249-272. PubMed ID: 38175479
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile Biofilm.
Vuotto C; Donelli G; Buckley A; Chilton C
Adv Exp Med Biol; 2018; 1050():97-115. PubMed ID: 29383666
[TBL] [Abstract][Full Text] [Related]
3. High sporulation and overexpression of virulence factors in biofilms and reduced susceptibility to vancomycin and linezolid in recurrent Clostridium [Clostridioides] difficile infection isolates.
Tijerina-Rodríguez L; Villarreal-Treviño L; Baines SD; Morfín-Otero R; Camacho-Ortíz A; Flores-Treviño S; Maldonado-Garza H; Rodríguez-Noriega E; Garza-González E
PLoS One; 2019; 14(7):e0220671. PubMed ID: 31365590
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial Activity of Tannic Acid
Wang W; Cao J; Yang J; Niu X; Liu X; Zhai Y; Qiang C; Niu Y; Li Z; Dong N; Wen B; Ouyang Z; Zhang Y; Li J; Zhao M; Zhao J
Microbiol Spectr; 2023 Feb; 11(1):e0261822. PubMed ID: 36537806
[TBL] [Abstract][Full Text] [Related]
5. Intestinal Inflammation Reversibly Alters the Microbiota to Drive Susceptibility to Clostridioides difficile Colonization in a Mouse Model of Colitis.
Barron MR; Sovacool KL; Abernathy-Close L; Vendrov KC; Standke AK; Bergin IL; Schloss PD; Young VB
mBio; 2022 Aug; 13(4):e0190422. PubMed ID: 35900107
[TBL] [Abstract][Full Text] [Related]
6. Multiple factors modulate biofilm formation by the anaerobic pathogen Clostridium difficile.
Ðapa T; Leuzzi R; Ng YK; Baban ST; Adamo R; Kuehne SA; Scarselli M; Minton NP; Serruto D; Unnikrishnan M
J Bacteriol; 2013 Feb; 195(3):545-55. PubMed ID: 23175653
[TBL] [Abstract][Full Text] [Related]
7. Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.
Lesniak NA; Schubert AM; Sinani H; Schloss PD
mSphere; 2021 May; 6(3):. PubMed ID: 33952668
[TBL] [Abstract][Full Text] [Related]
8. Diluted Fecal Community Transplant Restores Clostridioides difficile Colonization Resistance to Antibiotic-Perturbed Murine Communities.
Lesniak NA; Tomkovich S; Henry A; Taylor A; Colovas J; Bishop L; McBride K; Schloss PD
mBio; 2022 Aug; 13(4):e0136422. PubMed ID: 35913161
[TBL] [Abstract][Full Text] [Related]
9. Whole-Genome Sequencing Reveals the High Nosocomial Transmission and Antimicrobial Resistance of Clostridioides difficile in a Single Center in China, a Four-Year Retrospective Study.
Wen X; Shen C; Xia J; Zhong LL; Wu Z; Ahmed MAEE; Long N; Ma F; Zhang G; Wu W; Luo J; Xia Y; Dai M; Zhang L; Liao K; Feng S; Chen C; Chen Y; Luo W; Tian GB
Microbiol Spectr; 2022 Feb; 10(1):e0132221. PubMed ID: 35019676
[TBL] [Abstract][Full Text] [Related]
10. Ridinilazole: a novel, narrow-spectrum antimicrobial agent targeting Clostridium (Clostridioides) difficile.
Collins DA; Riley TV
Lett Appl Microbiol; 2022 Sep; 75(3):526-536. PubMed ID: 35119124
[TBL] [Abstract][Full Text] [Related]
11. Biofilm formation by Clostridium difficile.
Dapa T; Unnikrishnan M
Gut Microbes; 2013; 4(5):397-402. PubMed ID: 23892245
[TBL] [Abstract][Full Text] [Related]
12. The role of single and mixed biofilms in
Zhong S; Yang J; Huang H
Crit Rev Microbiol; 2024 May; 50(3):285-299. PubMed ID: 36939635
[No Abstract] [Full Text] [Related]
13. Efficacy and Safety of RBX2660 in PUNCH CD3, a Phase III, Randomized, Double-Blind, Placebo-Controlled Trial with a Bayesian Primary Analysis for the Prevention of Recurrent Clostridioides difficile Infection.
Khanna S; Assi M; Lee C; Yoho D; Louie T; Knapple W; Aguilar H; Garcia-Diaz J; Wang GP; Berry SM; Marion J; Su X; Braun T; Bancke L; Feuerstadt P
Drugs; 2022 Oct; 82(15):1527-1538. PubMed ID: 36287379
[TBL] [Abstract][Full Text] [Related]
14. Effect of antibiotic to induce Clostridioides difficile-susceptibility and infectious strain in a mouse model of Clostridioides difficile infection and recurrence.
Castro-Córdova P; Díaz-Yáñez F; Muñoz-Miralles J; Gil F; Paredes-Sabja D
Anaerobe; 2020 Apr; 62():102149. PubMed ID: 31940467
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance in Clostridioides difficile.
O'Grady K; Knight DR; Riley TV
Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2459-2478. PubMed ID: 34427801
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of fidaxomicin on biofilm formation in Clostridioides difficile.
Hamada M; Yamaguchi T; Ishii Y; Chono K; Tateda K
J Infect Chemother; 2020 Jul; 26(7):685-692. PubMed ID: 32224190
[TBL] [Abstract][Full Text] [Related]
17. The association of a reduced susceptibility to moxifloxacin in causative Clostridium (Clostridioides) difficile strain with the clinical outcome of patients.
Krutova M; Capek V; Nycova E; Vojackova S; Balejova M; Geigerova L; Tejkalova R; Havlinova L; Vagnerova I; Cermak P; Ryskova L; Jezek P; Zamazalova D; Vesela D; Kucharova A; Nemcova D; Curdova M; Nyc O; Drevinek P
Antimicrob Resist Infect Control; 2020 Jun; 9(1):98. PubMed ID: 32605598
[TBL] [Abstract][Full Text] [Related]
18. Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection.
Normington C; Moura IB; Bryant JA; Ewin DJ; Clark EV; Kettle MJ; Harris HC; Spittal W; Davis G; Henn MR; Ford CB; Wilcox MH; Buckley AM
NPJ Biofilms Microbiomes; 2021 Feb; 7(1):16. PubMed ID: 33547298
[TBL] [Abstract][Full Text] [Related]
19. The
Wickramage I; Peng Z; Chakraborty S; Harmanus C; Kuijper EJ; Alrabaa S; Smits WK; Sun X
Microbiol Spectr; 2023 Jun; 11(3):e0377722. PubMed ID: 37125917
[TBL] [Abstract][Full Text] [Related]
20. Biofilm regulation in Clostridioides difficile: Novel systems linked to hypervirulence.
Taggart MG; Snelling WJ; Naughton PJ; La Ragione RM; Dooley JSG; Ternan NG
PLoS Pathog; 2021 Sep; 17(9):e1009817. PubMed ID: 34499698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
